Royalty Pharma plc (RPRXN)
BMV
Real-time Data
02:30 PM
Day's Range
1,049.2152 wk Range
665.90Overview - RPRXN - Royalty Pharma plc
Key Statistics
Valuation
Enterprise Value
8.10T
P/E (Trailing)
‪33.32‬
PEG Ratio
‪-0.47‬
Price / Sales (TTM)
‪239.06‬
Price / Book
‪4.03‬
EV / EBITDA
‪307.09‬
Profitability
Profit Margin
‪32.01%‬
Operating Margin
‪19.74%‬
Return on Assets
‪5.08%‬
Return on Equity
‪13.96%‬
Ownership
Shares Outstanding
875.98M
Float
415.52M
Held by Insiders
‪6.48%‬
Held by Institutions
‪87.30%‬
Price stats
Beta
‪0.42‬
50-Day Avg
‪907.90‬
200-Day Avg
‪789.57‬
Dividends
Payout Ratio
‪48.92%‬
Frequency
Quarterly
Market Cap - RPRXN - Royalty Pharma plc
Peers - RPRXN - Royalty Pharma plc
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- RPRXNBMVRoyalty Pharma plc606.27BMarket Cap+35.19%52-week change33.33P/E (Trailing)‪32.01%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.56P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.215.02BMarket Cap+3.02%52-week change176.04P/E (Trailing)‪2.14%‬Profit Margin
- ACADBMVAcadia Pharmaceuticals Inc.88.73BMarket Cap+1.17%52-week change13.21P/E (Trailing)‪33.41%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
Profile Summary - RPRXN - Royalty Pharma plc
About
Royalty Pharma plc is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences sector. The company acquires royalties entitling it to payments based on net sales of approved therapies and development-stage product candidates, partnering with innovators from…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
